| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $4.8M | +2.4% |
| SG&A Expense | $6.1M | -2.2% |
| Operating Income | -$11.0M | +0.2% |
| Pre-tax Income | -$10.9M | -22.2% |
| Income Tax | $8K | -7.9% |
| Net Income | -$11.0M | -22.2% |
| EPS (Basic) | -$2.25 | +5.1% |
| EPS (Diluted) | -$2.25 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.1M | -54.6% |
| Accounts Receivable | $912 | +291.4% |
| Current Assets | $3.0M | -42.3% |
| Total Assets | $5.0M | -31.7% |
| Current Liabilities | $1.1M | -22.4% |
| Total Liabilities | $1.2M | -26.3% |
| Stockholders' Equity | $3.8M | -33.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.2M | -10.2% |
| Capital Expenditures | $24K | +182.6% |
| Investing Cash Flow | -$183K | +51.8% |
| Financing Cash Flow | $8.9M | -33.0% |
| Free Cash Flow | -$11.2M | -10.4% |
| +5.1% |